Lysophosphatidylethanolamine (LysoPE) in health and disease: a narrative review of its pathophysiological mechanisms and translational potential as a biomarker.

Front Cell Dev Biol · 2026 · PMC13230105 · PMID 42245487

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

With the exception of C20:4, other LysoPE species also showed a decreasing trend in NASH, which aligns with the lipidomic changes observed in human NASH patients ( Furukawa et al., 2016 ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.